Is Vitassium Recommended for POTS?
Yes, Vitassium (or equivalent sodium chloride supplementation) is strongly recommended as a first-line foundational therapy for patients with POTS, as it provides the essential 10 grams of daily sodium needed to expand blood volume and reduce orthostatic symptoms.
Rationale Based on Guidelines
The 2020 Canadian Cardiovascular Society guidelines provide a Strong Recommendation for increasing blood volume through dietary interventions, specifically including daily oral NaCl intake of 10 g via high-salt foods, NaCl sachets, salt sticks, or salt tablets 1. Vitassium is a commercially available electrolyte supplement that delivers sodium chloride in a convenient capsule form, making it a practical method to achieve this recommended sodium intake.
Why Sodium Supplementation Works
- Volume expansion: Increased sodium intake promotes blood volume expansion, which directly counteracts the hypovolemia and venous pooling characteristic of POTS
- Reduces nocturnal diuresis: Combined with sleeping in head-up tilt position (>10°), sodium loading helps maintain intravascular volume
- First-line therapy: This is recommended as the initial therapeutic step alongside fluid intake of at least 3 L daily 1
Practical Implementation
Start with these foundational interventions before considering medications:
- Sodium: 10 g daily via Vitassium, salt tablets, salt sticks, or high-salt foods
- Fluids: Minimum 3 L daily oral intake
- Compression garments: Waist-high stockings (20-30 mm Hg) if tolerated
- Exercise training: Semi-recumbent position initially, at least 4 days/week for 30+ minutes
Important Caveats from FDA Labeling
The Vitassium drug label 2 indicates caution is required in patients with:
- Cardiac disease (especially those on digitalis)
- Severe renal insufficiency or chronic kidney disease
- Hypertension or hypernatremia
- Severe hepatic disease or cirrhosis
- Peripheral or pulmonary edema
- Toxemia of pregnancy
Monitor serum electrolytes (sodium, potassium, calcium, phosphorus) periodically, particularly in patients with renal impairment 2.
When to Add Pharmacotherapy
If symptoms remain disabling despite adequate sodium/fluid loading and lifestyle modifications, then consider pharmacological options 1:
- Midodrine (2.5-15 mg every 4 hours, up to 3 times daily) - particularly for hypotensive phenotype
- Low-dose propranolol (10-20 mg four times daily) - for high standing heart rates
- Ivabradine (2.5-7.5 mg twice daily) - emerging evidence shows significant heart rate reduction (-18.5 bpm standing) with favorable safety profile 3
Common Pitfall to Avoid
Do not skip non-pharmacological interventions in favor of medications alone. The guidelines emphasize that volume expansion through sodium and fluid intake should be the foundation, with medications added only if symptoms persist 1. Many patients experience meaningful improvement with sodium supplementation alone, avoiding the side effects and costs associated with prescription medications 4.
Avoid antacids containing aluminum, magnesium, or calcium when taking Vitassium, as they can bind phosphate and prevent absorption 2.